CIROK TABLET 500 mg

País: Singapur

Idioma: inglés

Fuente: HSA (Health Sciences Authority)

Ingredientes activos:

CIPROFLOXACIN

Disponible desde:

ZIWELL MEDICAL (S) PTE LTD

Código ATC:

J01MA02

Dosis:

500 mg

formulario farmacéutico:

TABLET, FILM COATED

Composición:

CIPROFLOXACIN 500 mg

Vía de administración:

ORAL

tipo de receta:

Prescription Only

Fabricado por:

KOREA UNITED PHARMACEUTICAL INC

Estado de Autorización:

ACTIVE

Fecha de autorización:

2001-06-21

Ficha técnica

CIROK
TABLETS
CIPROFLOXACIN 250MG, 500MG
COMPOSITION
Each tablet contains
Ciprofloxacin hydrochloride
……………………………………………….…………………
291 mg
(As ciprofloxacin 250 mg)
Ciprofloxacin hydrochloride
……………………………………………….…………………
582 mg
(As ciprofloxacin 500 mg)
DESCRIPTION
White, round film-coated tablets.
INDICATIONS
CIROK is indicated for the treatment of infections.
Treatment of infections caused by the following microorganism;
Escherichia coli, Shigella, Salmonella,
Citrobacter,
Klebsiella,
Enterobacter,
Serratia,
Hafnia
Proteus
(Indole
Positive
and
negative),
Pseudomonas, Neisseria, Acinetobacter, Streptococcus, Clamydia,
Staphylococcus, Corynebacterium,
Clostridium, Bacteroides.
Infections: Respiratory infections; ear, nose and throat infections;
mouth, tooth, genial inflammation, renal
or urinary tract infections, genital infections including gonorrhea;
gastrointestinal infections, biliation canal
infections; bone and joint infections, soft tissue infections;
gynecological and obstetrical infections,
septicemia, meningitis, peritonitis, ophthalmic infections.
1. DOSAGE AND ADMINISTRATION
The usual adult oral dosage of Ciprofloxacin hydrochloride (CIROK) for
mild to moderate infections is 250
~500 mg, twice a day. For more severe or complicated infections, a
dosage of 750 mg may be given twice
a day. For the treatment of acute infections, the usual duration is 5
to 10 days. Generally ciprofloxacin
should be continued for at least 3 days after the signs and symptoms
of infection have disappeared.
2. Impaired Renal Function
The following table provides dosage guidelines for use in patients
with impaired renal function: monitoring
of serum drug levels provides the most reliable basis for dosage
adjustment.
CREATININE CLEARANCE (ML/MIN)
DOSE
> 50
30 ~ 50
5 ~ 29
Patients on hemodialysis or
Peritoneal dialysis
See usual dosage
250 ~ 500 mg q 12 h
250 ~ 500 mg q 18 h
250 ~ 500 mg q 24 h
(after dialysis)
When only the serum crea